Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018.

The company had posted a net profit of Rs 60.1 crore in January-March period of 2016-17, Sanofi India said in a filing to BSE.

Total revenue from operations also rose to Rs 617.7 crore as against Rs 552.9 crore earlier, it added.

In a separate filing , the company said its board has approved appointment of Charles Billard as Chief Financial Officer and key Managerial Personnel with effect from July 1, 2018.

Shares of Sanofi India were today trading at Rs 4,890.85 per scrip on BSE, up 1.17 per cent from its previous close.

  • Related Posts

    CDSCO modifies norms for testing permissions to speed up drug approvals

    Applicants will now be required to submit finalised regulatory specifications upfront   In a move aimed at speeding up approvals for new drugs, the government has changed the way testing…

    British men jailed for smuggling cocaine into Bali

    Two British men have been jailed in Indonesia after being found guilty of smuggling cocaine into the holiday island of Bali. Kial Garth Robinson, 29, of Littlehampton, was sentenced to…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CDSCO modifies norms for testing permissions to speed up drug approvals

    CDSCO modifies norms for testing permissions to speed up drug approvals

    British men jailed for smuggling cocaine into Bali

    British men jailed for smuggling cocaine into Bali

    Andhra milk adulteration: Four dead, seven in critical condition

    Andhra milk adulteration: Four dead, seven in critical condition

    Allahabad HC rejects bail pleas of two accused in Phensedyl syrup case

    Allahabad HC rejects bail pleas of two accused in Phensedyl syrup case

    Indore Lab Under Scrutiny: Suspected of Issuing Manipulated Drug Reports Without Proper Testing,pious labs

    Indore Lab Under Scrutiny: Suspected of Issuing Manipulated Drug Reports Without Proper Testing,pious labs

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court

    Offences Under Chapter IV Of Drugs And Cosmetics Act Triable Only By Sessions Court, Not Magistrate: Supreme Court